PTGX logo

Protagonist Therapeutics, Inc. (PTGX) Operating Profit

Annual Operating Profit:

$252.84M+$346.50M(+369.98%)
December 31, 2024

Summary

  • As of today, PTGX annual operating income is $252.84 million, with the most recent change of +$346.50 million (+369.98%) on December 31, 2024.
  • During the last 3 years, PTGX annual operating profit has risen by +$378.69 million (+300.92%).
  • PTGX annual operating profit is now at all-time high.

Performance

PTGX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Quarterly Operating Profit:

-$46.42M-$4.38M(-10.42%)
September 30, 2025

Summary

  • As of today, PTGX quarterly operating income is -$46.42 million, with the most recent change of -$4.38 million (-10.42%) on September 30, 2025.
  • Over the past year, PTGX quarterly operating profit has dropped by -$4.97 million (-11.98%).
  • PTGX quarterly operating profit is now -122.50% below its all-time high of $206.31 million, reached on March 31, 2024.

Performance

PTGX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

TTM Operating Profit:

$19.01M-$4.97M(-20.72%)
September 30, 2025

Summary

  • As of today, PTGX TTM operating income is $19.01 million, with the most recent change of -$4.97 million (-20.72%) on September 30, 2025.
  • Over the past year, PTGX TTM operating profit has dropped by -$130.10 million (-87.25%).
  • PTGX TTM operating profit is now -92.48% below its all-time high of $252.84 million, reached on December 31, 2024.

Performance

PTGX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTGXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

PTGX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+370.0%-12.0%-87.3%
3Y3 Years+300.9%-43.7%+114.3%
5Y5 Years+414.0%-475.1%+129.7%

PTGX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+292.5%-122.5%at low-92.5%+112.4%
5Y5-Yearat high+292.5%-122.5%at low-92.5%+112.4%
All-TimeAll-Timeat high+292.5%-122.5%at low-92.5%+112.4%

PTGX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$46.42M(-10.4%)
$19.01M(-20.7%)
Jun 2025
-
-$42.04M(-117.7%)
$23.98M(-11.9%)
Mar 2025
-
-$19.31M(-115.2%)
$27.22M(-89.2%)
Dec 2024
$252.84M(+370.0%)
$126.78M(+405.8%)
$252.84M(+69.6%)
Sep 2024
-
-$41.45M(-6.9%)
$149.11M(-2.1%)
Jun 2024
-
-$38.79M(-118.8%)
$152.24M(+2.4%)
Mar 2024
-
$206.31M(+795.1%)
$148.68M(+258.8%)
Dec 2023
-$93.65M(+28.7%)
$23.05M(+160.1%)
-$93.65M(+38.9%)
Sep 2023
-
-$38.33M(+9.5%)
-$153.22M(-4.1%)
Jun 2023
-
-$42.35M(-17.6%)
-$147.19M(-0.6%)
Mar 2023
-
-$36.02M(+1.4%)
-$146.28M(-11.3%)
Dec 2022
-$131.37M(-4.4%)
-$36.52M(-13.0%)
-$131.37M(+1.1%)
Sep 2022
-
-$32.30M(+22.1%)
-$132.77M(+1.6%)
Jun 2022
-
-$41.44M(-96.3%)
-$134.90M(-7.5%)
Mar 2022
-
-$21.11M(+44.3%)
-$125.44M(+2.9%)
Dec 2021
-$125.84M(-95.1%)
-$37.92M(-10.1%)
-$129.25M(-17.3%)
Sep 2021
-
-$34.43M(-7.6%)
-$110.16M(-31.4%)
Jun 2021
-
-$31.98M(-28.3%)
-$83.81M(-19.3%)
Mar 2021
-
-$24.92M(-32.3%)
-$70.24M(-7.2%)
Dec 2020
-$64.52M
-$18.83M(-133.3%)
-$65.52M(-2.4%)
Sep 2020
-
-$8.07M(+56.2%)
-$63.98M(+13.2%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$18.42M(+8.8%)
-$73.68M(+17.0%)
Mar 2020
-
-$20.20M(-16.8%)
-$88.73M(-5.9%)
Dec 2019
-$80.52M(-90.5%)
-$17.30M(+2.6%)
-$83.81M(-2.3%)
Sep 2019
-
-$17.77M(+46.9%)
-$81.92M(-11.4%)
Jun 2019
-
-$33.47M(-119.0%)
-$73.54M(-49.1%)
Mar 2019
-
-$15.28M(+0.9%)
-$49.32M(-16.7%)
Dec 2018
-$42.27M(-11.5%)
-$15.41M(-64.1%)
-$42.27M(-39.2%)
Sep 2018
-
-$9.39M(-1.6%)
-$30.37M(-17.0%)
Jun 2018
-
-$9.24M(-12.3%)
-$25.96M(+18.5%)
Mar 2018
-
-$8.23M(-134.2%)
-$31.85M(+15.9%)
Dec 2017
-$37.90M(-16.0%)
-$3.51M(+29.5%)
-$37.90M(+17.2%)
Sep 2017
-
-$4.98M(+67.1%)
-$45.78M(+4.5%)
Jun 2017
-
-$15.13M(-6.0%)
-$47.94M(-20.2%)
Mar 2017
-
-$14.27M(-25.2%)
-$39.90M(-22.1%)
Dec 2016
-$32.67M(-120.8%)
-$11.40M(-59.7%)
-$32.67M(-53.6%)
Sep 2016
-
-$7.14M(-0.7%)
-$21.27M(-50.5%)
Jun 2016
-
-$7.09M(-0.7%)
-$14.13M(-100.7%)
Mar 2016
-
-$7.04M(-161.8%)
-$7.04M(-161.8%)
Dec 2015
-$14.79M(-58.8%)
-
-
Mar 2015
-
-$2.69M
-$2.69M
Dec 2014
-$9.32M
-
-

FAQ

  • What is Protagonist Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Protagonist Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Protagonist Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Protagonist Therapeutics, Inc.?
  • What is Protagonist Therapeutics, Inc. TTM operating profit year-on-year change?

What is Protagonist Therapeutics, Inc. annual operating income?

The current annual operating profit of PTGX is $252.84M

What is the all-time high annual operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high annual operating income is $252.84M

What is Protagonist Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, PTGX annual operating income has changed by +$346.50M (+369.98%)

What is Protagonist Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of PTGX is -$46.42M

What is the all-time high quarterly operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high quarterly operating income is $206.31M

What is Protagonist Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, PTGX quarterly operating income has changed by -$4.97M (-11.98%)

What is Protagonist Therapeutics, Inc. TTM operating income?

The current TTM operating profit of PTGX is $19.01M

What is the all-time high TTM operating profit for Protagonist Therapeutics, Inc.?

Protagonist Therapeutics, Inc. all-time high TTM operating income is $252.84M

What is Protagonist Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, PTGX TTM operating income has changed by -$130.10M (-87.25%)
On this page